Is [99m]Tc-MIBI scintigraphy a predictor of response to pre-operative neoadjuvant chemotherapy in osteosarcoma?

Mohammad, Gharehdaghi; Vahid Reza Dabbagh, Kakhki; Alireza, Khooei; Gholamhosein, Novferesti; Alireza, Hootkani; Mahdi, Farzadnia; Ramin, Sadeghi

Mohammad, Gharehdaghi; Vahid Reza Dabbagh, Kakhki; Alireza, Khooei; Gholamhosein, Novferesti; Alireza, Hootkani; Mahdi, Farzadnia; Ramin, Sadeghi.

Asia Oceania Journal of Nuclear Medicine and Biology. 2013; 1 (2): 22-27

in En | IMEMR | ID: emr-138168

Responsible library: EMRO

Subject(s)

Humans; Female; Male; Neoadjuvant Therapy; Bone Neoplasms; Technetium Tc 99m Sestamibi; Chemotherapy, Adjuvant; Osteosarcoma/surgery

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Bone Neoplasms / Osteosarcoma / Chemotherapy, Adjuvant / Technetium Tc 99m Sestamibi / Neoadjuvant Therapy Limits: Female / Humans / Male Language: En Journal: Asia Oceania J. Nucl. Med. Biol. Year: 2013

Search on Google

Add to My VHL

XML